Hybrid nanoparticles for combination therapy of cancer
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 219, 224-236
- https://doi.org/10.1016/j.jconrel.2015.09.029
Abstract
No abstract availableKeywords
Funding Information
- NIH (U01-CA151455)
- University of Chicago Medicine Comprehensive Cancer Center (P30 CA014599)
This publication has 106 references indexed in Scilit:
- Biodegradable Polysilsesquioxane Nanoparticles as Efficient Contrast Agents for Magnetic Resonance ImagingSmall, 2013
- Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistanceInternational Journal of Nanomedicine, 2012
- Monodisperse Magnetic Nanoparticles for Theranostic ApplicationsAccounts of Chemical Research, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and OptimizationChemical Reviews, 2010
- Metal–organic frameworks as potential drug carriersCurrent Opinion in Chemical Biology, 2010
- Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomyProceedings of the National Academy of Sciences, 2009
- Postsynthetic Modifications of Iron-Carboxylate Nanoscale Metal−Organic Frameworks for Imaging and Drug DeliveryJournal of the American Chemical Society, 2009
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Nanoscale Metal−Organic Frameworks as Potential Multimodal Contrast Enhancing AgentsJournal of the American Chemical Society, 2006